
An approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.
An approach to stabilize PBS-based formulations could provide a simple physiological solution for use of proteins in research, preclinical, diagnostics, and clinical studies, as well as commercial biotherapeutic products.
This study offers a strategy for stabilization of biotherapeutics for long-term frozen storage in PBS-based formulations.
The study demonstrates a systematic approach to stabilize PBS-formulated mAbs against freeze-thaw degradation.
Achieving multiproduct development within shortened timelines.
Published: August 1st 2011 | Updated:
Published: August 1st 2016 | Updated:
Published: September 1st 2016 | Updated:
Published: October 1st 2016 | Updated: